JP Stock MarketDetailed Quotes

4579 RaQualia Pharma

Watchlist
  • 418
  • -9-2.11%
20min DelayMarket Closed Apr 25 15:30 JST
10.22BMarket Cap-18.28P/E (Static)

RaQualia Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
63.45%3.11B
18.47%762.47M
75.06%648.58M
-34.85%1.9B
-59.98%405.71M
5.31%481.41M
-41.91%643.59M
9.20%370.49M
5.11%2.92B
-12.09%1.01B
Cost of revenue
155.36%625.76M
164.84%166.45M
1.86%60.53M
5.82%245.05M
-12.53%55.63M
5.95%67.14M
22.29%62.85M
11.67%59.43M
-27.78%231.59M
22.91%63.6M
Gross profit
49.85%2.48B
2.63%596.02M
89.04%588.05M
-38.35%1.66B
-63.16%350.08M
5.21%414.27M
-45.03%580.74M
8.74%311.07M
9.40%2.69B
-13.73%950.13M
Operating expense
35.20%2.7B
60.46%794.74M
29.45%543.53M
9.52%1.99B
-0.98%579.37M
12.39%498.97M
28.57%495.29M
3.44%419.89M
4.15%1.82B
16.87%585.12M
Selling and administrative expenses
59.63%991.24M
100.29%321.09M
21.78%184.52M
8.65%620.95M
-20.00%141.24M
26.97%167.88M
32.91%160.31M
6.59%151.53M
-7.86%571.54M
14.77%176.55M
-General and administrative expense
59.63%991.24M
100.29%321.09M
21.78%184.52M
8.65%620.95M
-20.00%141.24M
26.97%167.88M
32.91%160.31M
6.59%151.53M
-7.86%571.54M
14.77%176.55M
Research and development costs
24.14%1.7B
41.40%473.65M
33.78%359.01M
9.92%1.37B
7.23%438.13M
6.21%331.1M
26.59%334.98M
1.75%268.36M
10.76%1.25B
17.80%408.58M
Operating profit
36.75%-213.38M
-332.56%-198.72M
140.91%44.52M
-138.95%-337.37M
-162.82%-229.29M
-68.71%-84.71M
-87.27%85.45M
9.20%-108.82M
22.37%866.24M
-39.23%365.01M
Net non-operating interest income (expenses)
-3,517.91%-35.75M
-6,189.05%-13.21M
148.87%1.75M
88.00%-988K
113.14%2.08M
439.39%712K
-107.15%-210K
-178.60%-3.57M
-138.71%-8.24M
-430.64%-15.85M
Non-operating interest income
-14.69%8.27M
-51.65%776K
142.98%3.81M
-28.98%9.7M
180.48%4.21M
27.83%2.32M
-68.02%1.61M
-70.56%1.57M
-40.23%13.66M
-71.91%1.5M
Non-operating interest expense
537.85%42.62M
814.41%13.9M
29.08%1.94M
11.44%6.68M
17.80%2.05M
-4.53%1.6M
-18.72%1.52M
113.92%1.51M
312.31%6M
217.30%1.74M
Total other finance cost
-64.97%1.4M
-71.53%84K
-96.70%120K
-74.81%4.01M
-99.52%75K
--0
39.81%295K
4,682.89%3.64M
13,147.50%15.9M
--15.61M
Net investment income
-25.07%38.99M
-61.06%32.66M
557.60%42.03M
19.09%52.04M
57.02%-59.64M
101.57%21.41M
-23.54%83.87M
-89.72%6.39M
-70.01%43.7M
-853.17%-138.76M
Gain(Loss) on financial instruments designated as cash flow hedges
12.51%-21.92M
14.36%-25.25M
-209.47%-26.53M
-283.26%-25.06M
5.53%21.71M
-123.50%-8.71M
3.45%-29.48M
36.22%-8.57M
235.65%13.67M
1,659.36%20.57M
Gain(Loss) on derecognition of available-for-sale financial assets
-20.14%2.19M
172.73%600K
-52.01%2.53M
105.91%2.74M
100.23%130K
-503.22%-2.88M
-97.75%220K
2,119.16%5.27M
-377.85%-46.35M
-508.60%-56.6M
Income from associates and other participating interests
Special income (charges)
-17.8M
0
Less:Other special charges
----
----
----
----
----
----
----
----
--17.8M
--0
Other non-operating income (expenses)
-976.81%-127.87M
-36.94%4.34M
-19,155.91%-138.45M
7,011.37%14.58M
131.69%8.07M
120.70%348K
578.91%6.88M
-24.61%-719K
75.12%-211K
2,222.67%3.48M
Income before tax
-21.66%-357.73M
-236.01%-199.58M
32.60%-74.16M
-134.55%-294.05M
-244.47%-256.94M
-2,103.19%-73.83M
-80.74%146.74M
-29.09%-110.02M
-3.36%851.01M
-72.06%177.85M
Income tax
363.66%137.3M
270.30%46.18M
-89.70%3.95M
-76.80%29.61M
35.03%-50.91M
6,853.31%69.29M
-115.83%-27.12M
7.51%38.35M
2.27%127.62M
-256.33%-78.37M
Net income
-52.95%-495.03M
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.03M
-6,052.97%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
Net income continuous operations
-52.95%-495.03M
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.02M
-6,055.61%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
Noncontrolling interests
0
0
Net income attributable to the company
-52.95%-495.03M
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.03M
-6,052.97%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-52.95%-495.03M
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.03M
-6,052.97%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
Gross dividend payment
Basic earnings per share
-52.67%-22.87
-240.94%-11.36
47.53%-3.61
-143.42%-14.98
-177.99%-9.53
-5,425.00%-6.63
-71.39%8.06
-19.24%-6.88
-4.35%34.5
-56.34%12.22
Diluted earnings per share
-52.67%-22.87
-241.25%-11.36
47.53%-3.61
-143.46%-14.98
-178.11%-9.53
-5,425.00%-6.63
-71.43%8.0426
-19.24%-6.88
-4.36%34.47
-56.38%12.2
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 63.45%3.11B18.47%762.47M75.06%648.58M-34.85%1.9B-59.98%405.71M5.31%481.41M-41.91%643.59M9.20%370.49M5.11%2.92B-12.09%1.01B
Cost of revenue 155.36%625.76M164.84%166.45M1.86%60.53M5.82%245.05M-12.53%55.63M5.95%67.14M22.29%62.85M11.67%59.43M-27.78%231.59M22.91%63.6M
Gross profit 49.85%2.48B2.63%596.02M89.04%588.05M-38.35%1.66B-63.16%350.08M5.21%414.27M-45.03%580.74M8.74%311.07M9.40%2.69B-13.73%950.13M
Operating expense 35.20%2.7B60.46%794.74M29.45%543.53M9.52%1.99B-0.98%579.37M12.39%498.97M28.57%495.29M3.44%419.89M4.15%1.82B16.87%585.12M
Selling and administrative expenses 59.63%991.24M100.29%321.09M21.78%184.52M8.65%620.95M-20.00%141.24M26.97%167.88M32.91%160.31M6.59%151.53M-7.86%571.54M14.77%176.55M
-General and administrative expense 59.63%991.24M100.29%321.09M21.78%184.52M8.65%620.95M-20.00%141.24M26.97%167.88M32.91%160.31M6.59%151.53M-7.86%571.54M14.77%176.55M
Research and development costs 24.14%1.7B41.40%473.65M33.78%359.01M9.92%1.37B7.23%438.13M6.21%331.1M26.59%334.98M1.75%268.36M10.76%1.25B17.80%408.58M
Operating profit 36.75%-213.38M-332.56%-198.72M140.91%44.52M-138.95%-337.37M-162.82%-229.29M-68.71%-84.71M-87.27%85.45M9.20%-108.82M22.37%866.24M-39.23%365.01M
Net non-operating interest income (expenses) -3,517.91%-35.75M-6,189.05%-13.21M148.87%1.75M88.00%-988K113.14%2.08M439.39%712K-107.15%-210K-178.60%-3.57M-138.71%-8.24M-430.64%-15.85M
Non-operating interest income -14.69%8.27M-51.65%776K142.98%3.81M-28.98%9.7M180.48%4.21M27.83%2.32M-68.02%1.61M-70.56%1.57M-40.23%13.66M-71.91%1.5M
Non-operating interest expense 537.85%42.62M814.41%13.9M29.08%1.94M11.44%6.68M17.80%2.05M-4.53%1.6M-18.72%1.52M113.92%1.51M312.31%6M217.30%1.74M
Total other finance cost -64.97%1.4M-71.53%84K-96.70%120K-74.81%4.01M-99.52%75K--039.81%295K4,682.89%3.64M13,147.50%15.9M--15.61M
Net investment income -25.07%38.99M-61.06%32.66M557.60%42.03M19.09%52.04M57.02%-59.64M101.57%21.41M-23.54%83.87M-89.72%6.39M-70.01%43.7M-853.17%-138.76M
Gain(Loss) on financial instruments designated as cash flow hedges 12.51%-21.92M14.36%-25.25M-209.47%-26.53M-283.26%-25.06M5.53%21.71M-123.50%-8.71M3.45%-29.48M36.22%-8.57M235.65%13.67M1,659.36%20.57M
Gain(Loss) on derecognition of available-for-sale financial assets -20.14%2.19M172.73%600K-52.01%2.53M105.91%2.74M100.23%130K-503.22%-2.88M-97.75%220K2,119.16%5.27M-377.85%-46.35M-508.60%-56.6M
Income from associates and other participating interests
Special income (charges) -17.8M0
Less:Other special charges ----------------------------------17.8M--0
Other non-operating income (expenses) -976.81%-127.87M-36.94%4.34M-19,155.91%-138.45M7,011.37%14.58M131.69%8.07M120.70%348K578.91%6.88M-24.61%-719K75.12%-211K2,222.67%3.48M
Income before tax -21.66%-357.73M-236.01%-199.58M32.60%-74.16M-134.55%-294.05M-244.47%-256.94M-2,103.19%-73.83M-80.74%146.74M-29.09%-110.02M-3.36%851.01M-72.06%177.85M
Income tax 363.66%137.3M270.30%46.18M-89.70%3.95M-76.80%29.61M35.03%-50.91M6,853.31%69.29M-115.83%-27.12M7.51%38.35M2.27%127.62M-256.33%-78.37M
Net income -52.95%-495.03M-241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.03M-6,052.97%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M
Net income continuous operations -52.95%-495.03M-241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.02M-6,055.61%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M
Noncontrolling interests 00
Net income attributable to the company -52.95%-495.03M-241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.03M-6,052.97%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -52.95%-495.03M-241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.03M-6,052.97%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M
Gross dividend payment
Basic earnings per share -52.67%-22.87-240.94%-11.3647.53%-3.61-143.42%-14.98-177.99%-9.53-5,425.00%-6.63-71.39%8.06-19.24%-6.88-4.35%34.5-56.34%12.22
Diluted earnings per share -52.67%-22.87-241.25%-11.3647.53%-3.61-143.46%-14.98-178.11%-9.53-5,425.00%-6.63-71.43%8.0426-19.24%-6.88-4.36%34.47-56.38%12.2
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More